Stephanie Mackey, Pallavi Singh, Gretchen J. Darlington – 30 December 2003

Gitte Irene Strauss, Kirsten Møller, Fin Stolze Larsen, Jens Kondrup, Gitte Moos Knudsen – 30 December 2003 – Hyperammonemia and hyperventilation are consistent findings in patients with fulminant hepatic failure (FHF), which may interfere with cerebral glucose and oxygen metabolism. The aim of the present study is to evaluate whether cerebral oxidative metabolism is preserved early in the course of FHF and whether hyperventilation has an influence on this. We included 16 patients with FHF, 5 patients with cirrhosis of the liver, and 8 healthy subjects.

Nicholas Onaca, Robert M. Goldstein, Goran B. Klintmalm – 30 December 2003

Lucia De Franceschi, Giovanna Fattovich, Franco Turrini, Kodjo Ayi, Carlo Brugnara, Franco Manzato, Franco Noventa, Anna Maria Stanzial, Pietro Solero, Roberto Corrocher – 30 December 2003 – The antiviral drug ribavirin (RBV) is widely used in combination with interferon (IFN) in the treatment of chronic hepatitis C virus (HCV) infection. A major side effect of RBV is a reversible hemolytic anemia. We have evaluated the in vitro effects of RBV on erythrocyte adenosine triphosphate (ATP) content and on hexosemonophosphate shunt (HMS).

Sandrine Godichaud, Stéphanie Krisa, Baptiste Couronné, Liliane Dubuisson, Jean‐Michel Mérillon, Alexis Desmoulière, Jean Rosenbaum – 30 December 2003 – Liver myofibroblasts are major actors in the development of liver fibrosis and cancer progression. There is a large interest in drugs that might deactivate these cells. Many studies have shown that the grapevine‐derived polyphenol, trans‐resveratrol, and other stilbenes have therapeutic potential in some diseases. In this work, we have studied the effect of grapevine polyphenols on cultured human liver myofibroblasts.

Anderson S. Gaweco, Russell H. Wiesner, Michael Porayko, Vinod K. Rustgi, Sherri Yong, Raza Hamdani, James Harig, Gregorio Chejfec, Kenneth D. McClatchey, David H. Van Thiel – 30 December 2003 – Nuclear factor κB (NF‐κB) is activated during viral infection and is central to the regulation of host immune responses. The NF‐κB activation status and its morphological sources were assessed by immunohistochemistry in allograft biopsy specimens of orthotopic liver transplantation patients with recurrent hepatitis C virus (HCV).

Josep M. Llovet, Jordi Bruix – 30 December 2003

Oliver Moennikes, Albrecht Buchmann, Klaus Willecke, Otto Traub, Michael Schwarz – 30 December 2003 – Mice deficient for connexin32 (Cx32), the major gap junction forming protein in liver, are highly susceptible to hepatocarcinogenesis. Because the Cx32 gene is located on the X‐chromosome, heterozygous females show mosaicism with respect to Cx32 expression; this enables their use in studying the effect of Cx32‐deficiency in a mixed Cx32‐plus/Cx32‐minus environment in vivo.

Jean‐François Cadranel, Pierre Rufat, Françoise Degos – 30 December 2003 – A nationwide prospective study was conducted in France in 89 university and primary referral hospitals' liver units to evaluate practices of liver biopsy and the occurrence of complications. A total of 2,084 biopsies were analyzed, recording the indication, hemostasis parameters, experience of operator, route of biopsy, use of ultrasonography (US), type of hospitalization, side effects, and complications. Pain, anxiety, and discomfort were evaluated by patients by visual analogue scale (VAS).

Cheng Liao, Mujun Zhao, Hai Song, Kiyoshi Uchida, Kazunari K. Yokoyama, Tsaiping Li – 30 December 2003 – Human chromosome 8p23 is known as a region that is associated with loss of heterozygosity (LOH), which is frequently deleted in hepatocellular carcinoma (HCC) tissues. We report here the characterization of a gene for a liver‐related putative tumor suppressor (LPTS) localized at 8p23, that was isolated by allelic‐loss mapping and positional candidate cloning.